ISO 9001:2015 certified WHO Good Distribution Practice certified 23 principal companies carried ₹44.99 Cr CFA operations in 2025–26 5 CFA & CSA mandates 200+ hospitals and pharmacies supplied 3 branches — Bangalore & Mangalore Cold 2–8°C · Cool 15–25°C · Ambient below 30°C Same-day availability confirmation

Home About us

About Mediline Biotex Pvt. Ltd.

We hold the stock everyone is waiting on.

Mediline Biotex Pvt. Ltd. is a Bangalore pharmaceutical supply chain company — warehousing, carrying & forwarding, super distribution and direct-to-patient supply for 23 principal companies, into more than 200 hospitals and pharmacies.

23Principal companies
5CFA & CSA mandates
200+Hospitals supplied
2Certifications held

Who we are

A warehouse business that behaves like a clinical partner.

Most of what a distributor does is invisible when it goes right. A consignment leaves a manufacturer, sits on a rack for a while, and arrives at a hospital pharmacy intact, on the date somebody promised. Nobody notices.

It gets noticed when it fails — when a batch cannot be traced, when a cold chain product arrives warm, when an oncology patient is told their cycle is postponed a week. We built this company around the parts that fail.

Three branches — two in Bangalore, on Sarjapur Main Road and Hosa Road, and one in Mangalore — sit behind multiple warehouses covering distribution, CFA and CSA operations, super distribution, retail supply and named-patient dispatch.

  • ISO 9001:2015 and WHO Good Distribution Practice certified
  • Batch and expiry controlled from goods-in to proof of delivery
  • Packing configurations matched to lane, season and transit time
  • Client SOPs followed as written — not adapted to ours
3Branches · 2 Bangalore, 1 Mangalore
MultiWarehouse network
9Therapy areas
Same dayEnquiry response

Certifications

Independently assessed, not self-declared.

Two certificates, both issued on 11 October 2025 and both covering the same scope: providing healthcare, hospital care and pharmaceutical products supply chain process. Click either to read the full certificate.

WHO Good Distribution Practice certificate of compliance for Mediline Biotex Pvt. Ltd.

WHO‑GDP

UK Certification and Assessment Ltd

Assessed and found working satisfactorily against Good Distribution Practice as laid down by the World Health Organization. This is the credential that matters most to a pharmaceutical principal evaluating a CFA partner — it covers storage conditions, traceability, transport and recall.

Certificate
Q-554011102025
Issued
11 October 2025
Valid until
10 October 2028
Accreditation
UAFL
Verify at ukascert.co.uk
ISO 9001:2015 certificate of registration for Mediline Biotex Pvt. Ltd.

ISO 9001:2015

QRO Certification LLP · EGAC accredited · IAF MLA

Quality Management System certification covering the same supply chain scope. In practice this is what keeps the SOPs written down, the records retained and the corrective actions closed — the discipline behind every claim on the rest of this site.

Certificate
305025101181Q
Certified
11 October 2025
Expiry
10 October 2028
Accreditation
EGAC · CAB #119005
Verify at qrocert.org

Both certificates are held by Mediline Biotex Pvt. Ltd. and are subject to annual surveillance audits. Copies are issued to principals and institutional buyers as part of onboarding, alongside our wholesale drug licences.

Financial track record

Six years of sales, in the open.

A distribution partner is only as useful as its balance sheet is stable. Ours is published here rather than offered on request.

FY 2026–27 · April to September

₹18.21Cr

Half a financial year already stands at 63% of the whole of 2025–26. At this run rate the company closes above every previous year, including the COVID allocation peak.

Best full year₹33.30 Cr
Last full year₹28.72 Cr
Growth 2024–25 → 2025–26+29%
CFA operations 2025–26₹44.99 Cr

Annual turnover

₹ crore · Indian financial years

Full year Part year
FY 2021-22₹33,30,05,660
Peak COVID allocation year
₹33.30 2021-22
FY 2022-23₹12,08,11,148
Post-COVID reset
₹12.08 2022-23
FY 2023-24₹24,62,84,417
Base business rebuilt
₹24.63 2023-24
FY 2024-25₹22,27,69,272 ₹22.28 2024-25
FY 2025-26₹28,71,91,648
Best full year since 2021-22
₹28.72 2025-26
FY 2026-27 · Apr–Sep₹18,21,00,000
Six months, April to September
₹18.21 2026-276 months

2021–22 was an exceptional year: Mediline Biotex Pvt. Ltd. was among the appointed distributors of Remdesivir in Karnataka and worked with the state government on COVID medicine distribution. The years since show the underlying business rebuilt from that reset — roughly 2.4× between 2022–23 and 2025–26, without allocation volumes behind it.

2025–26 at a glance

₹73.71 Cr of medicines moved through our warehouses

Our sales CFA operations

Our sales is Mediline Biotex Pvt. Ltd.'s own turnover as a stockist and distributor — the figure in the chart above.

CFA operations is principal stock we held, invoiced on the principal's behalf and despatched under five carrying & forwarding mandates. It is the principal's sale, not ours — but every rupee of it passed through our racks, our cold chain and our records.

What we run

Five operations, one stock position.

Pharmaceutical companies use us as a state or national CFA, or as a super distributor. Hospitals buy from us directly. All of it sits on the same racks, the same system and the same team.

01 / Distribution

Stockist & wholesale

Generic, branded and speciality medicines supplied to hospital pharmacies, chemists and institutional buyers across metro and non-metro cities.

02 / CFA & CSA

Carrying & forwarding

Five active mandates, ₹44.99 Cr of principal stock handled in 2025–26. We hold the stock, invoice on the principal's behalf and report back on movement, ageing and returns.

03 / Super distribution

Appointed super stockist

Three principals route their regional stock through us for onward distribution to sub-stockists and retail.

04 / Cold chain

Temperature-controlled

Cold, cool and ambient storage with packing configurations matched to transit time and lane rather than applied uniformly.

05 / Patient supply

Direct to patient

Named-patient supply of anti-cancer and speciality medicines, dispatched against prescription and coordinated with the treating hospital.

→

See the full portfolio

Nine therapeutic areas, three storage classes, six handling formats and the ordering process in detail.

Products

The whole job, in one line

Every dose arrives the way it left.

Twenty-three principals hand us their stock. Two hundred hospitals expect it intact, on the date we gave them. Everything between those two sentences is what we actually sell.

23Principals
5CFA mandates
200+Hospitals
3Storage bands

Principals

23 companies distribute through us.

Indian majors, multinationals and speciality innovators — grouped by the relationship we hold with each, because a CFA mandate and a supply arrangement are not the same commitment.

21 companies

Supply to corporate hospitals

Brands we carry and release into corporate hospital groups, medical colleges and institutional pharmacy.

Zydus LifesciencesLupin LimitedMacleods Pharmaceuticals Mylan PharmaceuticalsRA-Vish WellnessCorona Remedies Sayre TherapeuticsNatco PharmaTasmid India Kiosence HealthcareElbrit LifesciencesCelon Labs Cadila PharmaceuticalsVasu OrganicsAclaris Therapeutics Stanex Drugs & ChemicalsGraviti PharmaceuticalsIberia Skinbrands Surishi PharmaceuticalsConverge BiotechHealthium Medtech
5 mandates · ₹44.99 Cr in 2025–26

Carrying & forwarding

We hold the stock, invoice on the principal's behalf and report secondary sales on their cycle.

Natco PharmaConverge BiotechSayre Therapeutics Aclaris TherapeuticsCytosorbents India
3 appointments

Super distribution

Regional stock routed through us for onward supply to sub-stockists and retail pharmacy.

Surishi PharmaceuticalsStrassenburg PharmaceuticalsRA-Vish Wellness

Our story

From one warehouse to a certified national operation.

Dates before 2025 are indicative and pending confirmation from the company.

2020

Mediline Biotex Pvt. Ltd. established

Founded in Bangalore by Mrs. Nisha as a pharmaceutical supply chain warehouse, with Pramod Kumar joining as Director.

2021

COVID response

Appointed among the distributors of Remdesivir in Karnataka, and worked with the Government of Karnataka on state-wide COVID medicine distribution.

2022

CFA mandates begin

Carrying and forwarding operations added, including an all-India central warehouse alongside the Karnataka territories.

2023

200 customers

Hospital and pharmacy coverage passes 200 across metro and non-metro cities, with direct-to-patient oncology supply established.

Oct 2025

ISO 9001 and WHO‑GDP certified

Independently assessed against ISO 9001:2015 by QRO Certification and against WHO Good Distribution Practice by UK Certification and Assessment. Both valid to October 2028.

Today

23 principals, 5 mandates

Three branches — two in Bangalore and one in Mangalore — multiple warehouses, ₹44.99 Cr of CFA operations a year, and cold chain capability across three storage bands.

Facilities

Where the stock actually sits.

Racked pallet positions segregated by temperature band, with continuous monitoring and periodic mapping of storage areas.

Racked pallet positions in the warehouse
Racked pallet positions
Cartons staged for despatch
Despatch staging

See the full gallery

For pharmaceutical companies

Looking for a CFA partner in the Southern states?

Tell us the territory, the temperature band and the volumes. We come back with warehouse capacity, service levels and commercials.

Start a conversation

For hospitals & pharmacies

Need a molecule we stock?

Send the product, strength and quantity. Availability, batch and delivery window come back the same working day.

Check availability

Chat on WhatsApp